Vice President Ann Baker will moderate a session entitled “Covering all the bases: An integrated approach to strategic drug development.” John Cole will facilitate BIO-Europe’s Academic Innovators track, a series of presentations designed to bridge the gap and encourage collaboration between academia and the biopharma industry.
CRA is a silver sponsor and exhibitor for this annual conference. Visit us at booth #27.
For more information on this event, click here.
Rare disease PMA trends in France: Price achieved vs. disease prevalence
In this installment, we examine the relationship between launch prices in France and disease prevalence as reported in the Haute Autorité de Santé assessments.